Botulinum Toxin Injections
J15
20 active Medicare policies list 64616, and 6 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J15 · Effective Feb 22, 2026
J6 · Effective Feb 22, 2026
JK · Effective Feb 22, 2026
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Feb 22, 2026
JM · Effective Feb 22, 2026
J5
J5 · Effective Feb 22, 2026
6 policies from 5 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 64616 |
|---|---|---|
| Headaches: Invasive Procedures | Feb 20, 2024 | Covered |
| Selective Peripheral Denervation (Bertrand Procedure) | Jun 7, 2023 | Covered |
| Policy | Effective | Status of 64616 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 64616 |
|---|---|---|
J5
J8 · Effective Feb 22, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
National · Effective Apr 9, 2026
| Jan 1, 2026 |
| Covered |
| Policy | Effective | Status of 64616 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |
| Policy | Effective | Status of 64616 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2026 | Covered |